Journal of Natural Products
Article
̈
DMSO-d6 was purchased from Armar Chemicals (Dottingen,
Switzerland). Analytical-grade formic acid, XAD porous resin
(Amberlite, 20−60 mesh), analytical-grade EtOH, MeOH, DMSO,
anhydrous pyridine, caffeine for sensory analysis, L-ascorbic acid, L-
cysteine methyl ester hydrochloride, and hexamethyldisilazane/
trimethylchlorosilane/pyridine (3:1:9) were purchased from Merck.
L-Glucose and D-glucose were obtained from Acros Organics
(Thermo Fisher Scientific, Waltham, MA, USA), while L-rhamnose
and D-rhamnose were sourced from Carbosynth (Compton, UK).
HCl and analytical-grade EtOAc were purchased from Scharlau
(Scharlab S. L.) (Barcelona, Spain). Deionized water and ultrapure
water were prepared using an Elix and Milli-Q water purification
system (Merck).
18−25 min (23% B); 35 °C; flow rate 21.2 mL/min) to yield
compound 1 (80 mg, tR = 13.3 min; 97% purity based on LC-MS).
Isolation of Compounds after Heat Treatment. Compound 1
(15.1 mg) was dissolved in water (10 mg/mL) and heated for 4 h at
90 °C. The resulting mixture was purified by semipreparative RP-
HPLC [0.1% aq. formic acid (A), 0.1% formic acid in MeCN (B); 0−
5 min (5−15% B), 5−20 min (15% B), 20−40 min (15−60% B); flow
rate 4 mL/min; injection volume 4 × 250 μL, room temperature] to
yield compound 2 (3.1 mg, tR 14.4 min), compound 1 (5.3 mg, tR
15.9 min) and compound 3 (0.6 mg, tR = 28.1 min).
(2S)-5-[α-L-Rhamnopyranosyl-(1→2)-β-D-glucopyranosyloxy]-
naringenin (1): yellow, amorphous powder; [α]25 −68.0 (c 0.17,
MeOH); UV λmax (MeOH) (log ε) 227 (3.08), 281D(2.81) nm; ECD
(MeOH, c 1.8 × 10−4 M, 1 mm path length) λmax(Δε) 216 (+8.88),
Optical rotations were measured in MeOH on a Jasco P-2000
digital polarimeter (Tokyo, Japan) equipped with a sodium lamp (589
nm) and a 10 cm length temperature-controlled microcell. UV and
ECD spectra were recorded in MeOH on a Chirascan spectrometer
(Applied Photophysics, Leatherhead, UK) with 1 mm path precision
̈
cells 110 QS (HellmaAnalytics, Mullheim, Germany). NMR spectra
were recorded in DMSO-d6 on a Bruker AVANCE III 500 MHz
1
286 (−7.67), 331 (+3.42) nm; H and 13C NMR, see Table 1; HR-
ESIMS m/z 581.1865 [M + H]+ (calcd for C27H32O14+, 581.1865);
MSE fragment ions (negative ionization) m/z 459, 433, 313, 271*,
209, 169, 151, 145, 125.
(2R)-5-[α-L-Rhamnopyranosyl-(1→2)-β-D-glucopyranosyloxy]-
naringenin (2): yellow, amorphous powder; [α]25 −72.3 (c 0.25,
D
MeOH); UV λmax (MeOH) (log ε) 227 (2.91), 282 (2.63) nm; ECD
1
spectrometer (Billerica, CA, USA) operating at 500.13 MHz for H
(MeOH, c 1.7 × 10−4 M, 1 mm path length) λmax (Δε) 216 (−10.48),
and 125.77 MHz for 13C. Measurements were performed with a 1 mm
TXI probe at 18 °C. Data were processed with Bruker TopSpin 3.5
software. HR-ESIMS data were recorded in positive ion mode on a
Shimadzu LC-20A system (Kyoto, Japan) with a Thermo Scientific
Orbitrap LTQ XL detector (Waltham, CA, USA) and a Waters
SunFire C18 column (5 μm, 150 × 10 mm i.d.). Data acquisition was
recorded using Xcalibur 2.1 software. Fragmentation data (MSE using
a collision energy ramp from 20 to 60 V) were obtained by analysis in
the negative ion mode on an Acquity UPLC system coupled to a
Synapt G2 Q-TOF equipped with an electrospray ionization source
(Waters, Milford, MA, USA). The LC inlet method used a Kinetex
C18 column (2.6 μm, 150 × 4.6 mm, Phenomenex, Torrance, CA,
USA) as described by Beelders et al.6 Preparative HPLC was
performed on a Waters preparative LC, with autosampler, variable
UV−visible detector, and fraction collector, equipped with a Gemini-
NX C18 preparative column (5 μm; 150 × 21.2 mm, 100 Å;
Phenomenex), protected by a guard column with the same stationary
phase. Semipreparative HPLC was performed on an Agilent 1100
Series instrument with a DAD detector (Santa Clara, CA, USA) and
equipped with a Waters SunFire C18 column (5 μm, 150 × 10 mm
i.d.), protected by a guard column (10 × 10 mm i.d.; Waters). Data
acquisition and processing were performed using ChemStation
software. GC-MS analysis was performed on an Agilent G1530A
equipped with an RXI 5 MS column (25 m × 0.2 mm i.d., 0.3 μm).
Plant Material. Shoots of C. genistoides Vent. (genotype GK5 of
the ARC Honeybush Plant Breeding Programme) were harvested at
an evaluation site (GPS coord. −34.702, 19.618), shredded, dried (40
°C/16 h), and sieved to obtain the tea bag fraction (<1.68 mm, >0.42
mm; retention sample CGN_L0152).
1
235 (−6.57), 294 (+5.11), 329 (−4.55) nm; H and 13C NMR, see
+
Table 1; HR-ESIMS m/z 581.1865 [M + H]+ (calcd for C27H32O14
,
581.1865); MSE fragment ions (negative ionization) m/z 433, 271*,
227, 151, 145, 125, 119, 107.
E-2′-[α-L-Rhamnopyranosyl-(1→2)-β-D-glucopyranosyloxy]-
1
4′,6′,4-trihydroxychalcone (3): H and 13C NMR, see Table 1; HR-
ESIMS m/z 581.1879 [M + H]+ (calcd for C27H32O14+, 581.1865);
MSE fragment ions (negative ionization) m/z 271*, 169, 151, 145,
125, 107.
Sugar Analysis. Compound 1, 2, or 3 (0.5 mg) was heated at 105
°C for 1 h in 1 mL of 2 M HCl. After extraction with EtOAc, the
aqueous phase was lyophilized and resolubilized in 1 mL of anhydrous
pyridine. Derivatization with L-cysteine methyl ester hydrochloride
(200 μL, 60 °C, 1 h) and subsequently silylation with
hexamethyldisilazane and Me3SiH in pyridine (3:1:9; 200 μL; 60
°C, 30 min) were performed. Pyridine was evaporated prior to GC-
MS analysis. The column temperature was kept at 60 °C for 1 min
and then increased at 10 °C/min until 300 °C; L-rhamnose (tR 21.29
min), D-rhamnose (tR 21.39 min), D-glucose (tR 22.59 min), L-glucose
(tR 22.73 min).
Thermal Conversion of Compound 1. The thermal degradation
of 1 in 0.1 M phosphate buffer solution (pH 5) was assessed at five
temperatures (80, 90, 100, 110, and 120 °C). Similarly, naringin was
heated at 100 °C. The experiments were performed as previously
described.13 Aliquots (800 μL; n = 25) of the working solution of
each compound (58 μg/mL = 0.1 mM, dissolved 0.1 M phosphate
buffer solution) were transferred into 5 mL glass reaction vials
(Merck). One aliquot served as unheated control while the remaining
vials were heated in a preheated Stuart heating block with glycerin
added to the cavities to improve heat transfer. Replicate samples (n =
3) were randomly removed at predetermined time points (n = 8),
cooled, filtered (0.22 μm pore size, 4 mm diameter Millex-GV syringe
filters; Merck), and analyzed using UHPLC-DAD.13 The content of 1,
2, and naringin was quantified using the peak area at 288 nm.
Univariate analysis of variance (ANOVA) was performed on the
data sets for each temperature (SAS, version 9.4; SAS Institute, Cary,
NC, USA). The Shapiro−Wilk test was performed to test for
normality. Fisher’s least significant difference was calculated at the 5%
level (p < 0.05) to compare means across treatment times. The kinetic
data for compound 1 were fitted to zero-, first-, and second-order and
fractional conversion models by nonlinear regression, using SAS. The
fractional conversion model (eq 1) was selected based on goodness-
of-fit of predicted and actual data (R2).
Isolation of Compound 1. A freeze-dried, hot water extract (120
g), prepared from the plant material (600 g) as described by Beelders
et al.,23 was sonicated in EtOH (1:10 m/v) for 60 min. The EtOH-
soluble fraction was recovered and freeze-dried, and 15 g of the
fraction, suspended in 50 mL of HPLC-grade water, was further
fractionated on a dechlorinated XAD (Amberlite, 20−60 mesh)
column (68 × 500 mm). An EtOH/water gradient at a flow rate of 38
mL/min was employed: 0% EtOH (4.5 L), 5% EtOH (4.5 L), 10%
EtOH (6 L), 20% EtOH (4.5 L), 30% EtOH (4.5 L), 100% EtOH
(4.5 L). Column fractions (750 mL) were monitored by HPLC-DAD,
and those containing flavanones (fractions 29 to 38) were pooled,
vacuum-evaporated, and freeze-dried, yielding a 4 g fraction. An
aliquot of the XAD fraction (2 g) was dissolved at 5 mg/mL (as
limited by solubility) in a 23% MeOH/water solution containing 10%
DMSO (v/v), and 5000 μL (maximum capacity of injection loop)
was repeatedly injected on preparative HPLC, employing a gradient
solvent program (solvent A: 0.1% formic acid(aq); solvent B: 100%
MeOH): 0−2 min (23% B), 2−15 min (23−24% B), 15−16 min
(24−90% B), 16−17 min (90% B), 17−18 min (90−23% B), and
C = C∞ + (C0 − C∞)exp−kt
(1)
where C, C0, and C∞ are the concentration of compound 1 (mM) at
time t, time 0, and equilibrium conditions, respectively, t is the time in
h, and k is the reaction rate constant (h−1).
E
J. Nat. Prod. XXXX, XXX, XXX−XXX